YUNFEI WEI

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology DOWNEY, CA NPI 1801075684

General Payments — all program years on this page

$8,955.59

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 378
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $618.80 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $618.8021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,793.7083
2019 $4,021.94168
2020 $1,954.7783
2021 $264.7115
2022 $97.554
2023 $204.124
2024 $618.8021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078293301 Janssen Biotech, Inc. $34.72 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087438908 Novartis Pharmaceuticals Corporation $15.04 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089497166 Daiichi Sankyo Inc. $23.34 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093975307 Alexion Pharmaceuticals, Inc. $28.36 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094031385 Alexion Pharmaceuticals, Inc. $21.49 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101641616 E.R. Squibb & Sons, L.L.C. $13.12 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105775156 AstraZeneca Pharmaceuticals LP $115.42 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106318523 ABBVIE INC. $34.20 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106318525 ABBVIE INC. $17.87 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106318527 ABBVIE INC. $27.90 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113839232 PUMA BIOTECHNOLOGY, INC. $27.97 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114248727 Regeneron Healthcare Solutions, Inc. $33.08 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116464610 GlaxoSmithKline, LLC. $29.08 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118158777 Boehringer Ingelheim Pharmaceuticals, Inc. $38.53 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120850001 BeiGene USA, Inc. $34.55 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131380165 PFIZER INC. $22.95 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131849611 PFIZER INC. $20.13 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133136122 Genentech USA, Inc. $20.80 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133806097 Gilead Sciences, Inc. $28.17 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139427994 Astellas Pharma US Inc $13.56 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141759146 Merck Sharp & Dohme LLC $18.52 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.